We are live on ! Find out more
RCC

Red Cedar Capital Portfolio holdings

AUM $158M
1-Year Est. Return 6.57%
This Fund
S&P 500
This Quarter Est. Return
+12.86%
1 Year Est. Return
-6.57%
3 Year Est. Return
+42.97%
5 Year Est. Return
+80.53%
10 Year Est. Return
AUM
$117M
AUM Growth
+$14.2M
Cap. Flow
+$2.03M
Cap. Flow %
1.73%
Top 10 Hldgs %
52.7%
Holding
154
New
2
Increased
20
Reduced
4
Closed
3

Top Buys

Rank Stock Value
1
CAG icon
Conagra Brands
CAG
+$1.31M
2
MG icon
Mistras Group
MG
+$492K
3
WFC icon
Wells Fargo
WFC
+$80.7K
4
MFA
MFA Financial
MFA
+$69.5K
5
TAK icon
Takeda Pharmaceutical
TAK
+$61.5K

Sector Composition

Rank Sector Weight
1 Industrials 22.82%
2 Financials 16.65%
3 Consumer Discretionary 14.56%
4 Consumer Staples 14.21%
5 Healthcare 12.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
26
PepsiCo
PEP
$187B
$1.23M 1.04%
9,994
TJX icon
27
TJX Companies
TJX
$171B
$1.02M 0.87%
19,142
UNH icon
28
UnitedHealth
UNH
$387B
$1M 0.86%
4,062
KMX icon
29
CarMax
KMX
$8.14B
$883K 0.75%
12,644
MSFT icon
30
Microsoft
MSFT
$2.93T
$857K 0.73%
7,269
AAPL icon
31
Apple
AAPL
$4.9T
$783K 0.67%
16,500
MMM icon
32
3M
MMM
$83.4B
$778K 0.66%
4,477
OPLN
33
Openlane
OPLN
$4.18B
$767K 0.65%
39,522
+1,850
+5% +$34.9K
TEVA icon
34
Teva Pharmaceuticals
TEVA
$37.3B
$732K 0.62%
46,667
+380
+0.8% +$6.7K
BAC icon
35
Bank of America
BAC
$430B
$634K 0.54%
22,985
AXP icon
36
American Express
AXP
$242B
$579K 0.49%
5,300
CVS icon
37
CVS Health
CVS
$137B
$568K 0.48%
10,530
RDS.A
38
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$510K 0.43%
8,156
-121
-1% -$7.48K
BN icon
39
Brookfield
BN
$107B
$490K 0.42%
29,429
HD icon
40
Home Depot
HD
$338B
$490K 0.42%
2,553
AAP icon
41
Advance Auto Parts
AAP
$3.21B
$488K 0.42%
2,862
ALL icon
42
Allstate
ALL
$64.3B
$471K 0.4%
5,000
SCHX icon
43
Schwab US Large- Cap ETF
SCHX
$71.7B
$454K 0.39%
40,308
+228
+0.6% +$2.47K
AMGN icon
44
Amgen
AMGN
$198B
$433K 0.37%
2,280
BF.B icon
45
Brown-Forman Class B
BF.B
$11.7B
$420K 0.36%
7,954
BAX icon
46
Baxter International
BAX
$11.7B
$398K 0.34%
4,893
MCO icon
47
Moody's
MCO
$89.2B
$375K 0.32%
2,070
COF icon
48
Capital One
COF
$128B
$369K 0.31%
4,512
DOX icon
49
Amdocs
DOX
$5.59B
$345K 0.29%
6,380
NVS icon
50
Novartis
NVS
$293B
$302K 0.26%
3,504

Similar funds

Red Cedar Capital's Q1 2019 Portfolio in Review

As of Q1 2019, Red Cedar Capital held 154 positions worth $117M, up 14% from $103M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 3.2%. Red Cedar Capital opened 2 new positions and exited 3, leaving the 154-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Red Cedar Capital's largest Q1 2019 buy was Takeda Pharmaceutical: 3,054 shares worth $62K.
  • Red Cedar Capital added most to Conagra Brands in Q1 2019, an estimated $1.31M increase.
  • Red Cedar Capital's biggest Q1 2019 reduction was Royal Dutch Shell PLC ADS Class A, cutting an estimated $7.48K.
  • Red Cedar Capital fully exited Shire pic in Q1 2019, selling an estimated $106K.
  • Red Cedar Capital's ten largest holdings make up 53% of its $117M portfolio in Q1 2019.
  • Red Cedar Capital opened 2 new positions and closed 3 in Q1 2019.
  • Red Cedar Capital's portfolio value rose 14% quarter-over-quarter to $117M.

Based on Red Cedar Capital's 13F filing for Q1 2019, filed 7 May 2019.